Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy.

M J Coppes; R Lau; L C Ingram; J T Wiernikowski; R Grant; D R Howard; M Perrotta; R Barr; E Dempsey; M L Greenberg

doi:10.1002/(sici)1096-911x(199908)33:2<99::aid-mpo7>3.0.co;2-p

Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy.

Identifier:nobleid.org/w1/20260515/9CF89EC3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/9CF89EC3.svg?ark=w1%2F20260515%2F9CF89EC3)](https://nobleid.org/work/w1/20260515/9CF89EC3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy.

Identifier:nobleid.org/w1/20260515/9CF89EC3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/9CF89EC3.svg?ark=w1%2F20260515%2F9CF89EC3)](https://nobleid.org/work/w1/20260515/9CF89EC3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work